Studies provide new insights on mosquito-borne chikungunya virus infection

December 20, 2017, Wiley

The frequency of chronic joint pain after infection with chikungunya in a large Latin American cohort was 25% at a median of 20-months post-infection. In the Arthritis & Rheumatology study, significant predictors of persistent joint pain included being a college graduate, headache, knee pain, missed work, normal activities effected, four or more days of initial symptoms, and four or more weeks of initial joint pain.

The finding of chronic in one fourth of the patients infected with chikungunya, a mosquito-borne illness, approximately two years after initial infection has important implications for prediction of the magnitude of disability and health system costs after the Latin American epidemic.

The investigators hypothesized that persistent active chikungunya is responsible for chronic arthritis and joint and that chikungunya viral RNA would be present in the synovial fluid; however, in another study published in Arthritis & Rheumatology, the researchers did not detect viable virus after culture of synovial fluid in any of the participants who were studied for a median 22 months after infection.

Explore further: Tropical virus symptoms can mimic rheumatoid arthritis, study says

More information: Aileen Y. Chang et al, A cross-sectional analysis of chikungunya arthritis patients 22-months post-infection demonstrate no detectable viral persistence in synovial fluid, Arthritis & Rheumatology (2017). DOI: 10.1002/art.40383

Related Stories

Tropical virus symptoms can mimic rheumatoid arthritis, study says

February 21, 2015
(HealthDay)—The mosquito-borne chikungunya virus causes joint pain and swelling similar to rheumatoid arthritis, which can make diagnosis difficult, a new study says.

Drug combination effective against chikungunya arthritis in mice

February 1, 2017
Combining a drug for rheumatoid arthritis with one that targets the chikungunya virus can eliminate the signs of chikungunya arthritis in mice in the disease's earliest stage, according to researchers at Washington University ...

Chikungunya vaccine trial underway

June 6, 2017
The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor College of Medicine will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya ...

Mosquito-borne chikungunya virus still a concern for American travelers, CDC says

November 6, 2014
(HealthDay)—Americans traveling to the Caribbean and Central and South America this winter need to be aware that an outbreak of the mosquito-borne disease chikungunya continues to spread in those areas, U.S. federal health ...

Confirmed cases of chikungunya soar in Brazil

November 24, 2016
Brazil's Health Ministry says that cases of chikungunya are soaring this year in Latin America's biggest country.

The signature of Chikungunya

August 31, 2015
Infection with the Chikungunya virus produces a 'signature' pattern of immune messenger molecules in the blood, according to the latest research from A*STAR scientists1. This discovery will hopefully improve patients' prognoses, ...

Recommended for you

Tibetan sheep highly susceptible to human plague, originates from marmots

August 16, 2018
In the Qinghai-Tibet plateau, one of the region's highest risk areas for human plague, Himalayan marmots are the primary carriers of the infectious bacterium Y. pestis. Y. pestis infection can be transmitted to humans and ...

Autoimmunity plays role in development of COPD, study finds

August 16, 2018
Autoimmunity plays a role in the development of chronic obstructive pulmonary disease (COPD), according to a study led by Georgia State University and Vanderbilt University Medical Center that analyzed human genome information ...

Reliable point-of-care blood test can help prevent toxoplasmosis

August 16, 2018
A recent study, performed in Chicago and Rabat, Morocco, found that a novel finger-prick test for infection with the parasite Toxoplasma gondii during pregnancy—and many other potential applications—is 100 percent sensitive ...

Scientists identify nearly 200 potential tuberculosis drug targets

August 16, 2018
Tuberculosis is one of the top 10 causes of death worldwide. Nearly 2 million people die every year from this infectious disease, and an estimated 2 billion people are chronically infected. The only vaccine, developed almost ...

First mouse model to mimic lung disease could speed discovery of more effective treatments

August 16, 2018
The biggest hurdle to finding effective therapies for idiopathic pulmonary fibrosis (IPF) – a life-threatening condition in which the lungs become scarred and breathing is increasingly difficult – has been the inability ...

Anticancer drug offers potential alternative to transplant for patients with liver failure

August 15, 2018
Patients suffering sudden liver failure could in the future benefit from a new treatment that could reduce the need for transplants, research published today shows.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.